Product
Study Medication
1 clinical trial
2 indications
Indication
Diabetes MellitusIndication
Type 1Clinical trial
A Randomized, Placebo-controlled, Double-blinded Cross-over Study of the Pharmacologic Action of a GPR119 Agonist on Glucagon Counter-regulation During Insulin-induced Hypoglycemia in Type 1 Diabetes MellitusStatus: Active (not recruiting), Estimated PCD: 2022-11-11